A New Approach to Clinical Trial Planning: How Mid and Emerging Pharma Can Take Greater Control of Patient Enrollment

Mid-size and emerging pharma face the same enrollment pressures as large pharma, but with fewer resources, less data, and little room for error. Join us to learn how leaders are making more confident country and site decisions, building forecasts they can trust, and proactively adapting as studies unfold to achieve enrollment goals faster.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/new-approach

Event overview:

Mid-size and emerging pharma companies face the same enrollment pressures as large pharma but must navigate them with fewer resources, less historical data, and limited room for error. As a result, every country selection, site recommendation, and enrollment assumption carries outsized impact on study timelines, costs, and development milestone achievement.

This webinar explores how clinical development and operations teams can make more confident country and site selection decisions, even when working with imperfect evidence and lean teams. The session will demonstrate how data-driven forecasting can improve planning confidence while reducing reliance solely on CRO insights and experience-driven inputs. It will also examine how continuous monitoring, early warning signals, and dynamic reforecasting can help identify risks sooner, enable faster intervention, and drive more predictable trial execution.

Key Learning Objectives:

• Identify the countries and sites most likely to accelerate recruitment with limited resources and imperfect evidence
• Create forecasts you can trust without relying solely on CRO assumptions or an army of analysts
• Adapt faster as studies evolve through continuous monitoring, early warning signals, and dynamic reforecasting

Who Should Attend:
This webcast is designed for professionals involved in clinical trial planning, feasibility, and operational strategy, including:

• Clinical Operations: Vice Presidents, Heads, Global Heads, Executive Directors, Senior Directors, and Directors of Clinical Operations
• Study Feasibility: Heads of Study Feasibility, Directors of Study Feasibility, Feasibility Leads, Global Feasibility Leads, and Feasibility Managers
• Clinical Trial Planning: Clinical Trial Planning Leads
• Clinical Analytics & Innovation: Heads of Clinical Analytics, Clinical Operations Analytics Leads, Clinical Data Science Leads, Directors of Clinical Planning & Analytics, Clinical Innovation Leads, and Digital Clinical Operations Leads
• Clinical Program & Trial Management: Clinical Program Directors, Senior Clinical Program Directors, Clinical Trial Managers (CTMs), Senior Clinical Trial Managers, Global Trial Leads, and Program Operations Leads
• Clinical Technology & Digital Transformation: Vice Presidents and Heads of Clinical Technology, Directors of Clinical Systems, Directors of Clinical Technology & Innovation, Heads of Digital Clinical Operations, Directors of Digital Transformation (R&D), Heads of Clinical Data & Technology, and Clinical Technology Strategy Leads
  

Speakers:

Harini Lakshminarayanan
Director, Products
ZS Associates

Harini Lakshminarayanan is a product leader for ZS's ZAIDYN® Clinical platform, driving study planning. With 15-plus years of experience across biopharma R&D and clinical operations, she helps life sciences clients turn complex data into smarter decisions by translating deep clinical expertise into products that accelerate drug development.

Jennifer Baltzell
Principal
ZS Associates

Jennifer Baltzell is a principal at ZS who helps pharmaceutical and biotechnology companies transform how they plan and execute clinical development. With more than 20 years of experience leading large-scale business and digital transformation initiatives across the life sciences industry, she now focuses on applying AI, advanced analytics, and innovative operating models to improve study planning, enrollment forecasting, clinical operations, and trial performance.

Maria Kliatchko
GM, ZAIDYN Clinical
ZS Associates

Maria Kliatchko leads ZAIDYN® Clinical at ZS, helping life sciences organizations apply AI, analytics, and technology to improve clinical development planning and decision-making. With more than 25 years of experience across pharmaceutical, medical device, and healthcare organizations, she has advised clients on advancing analytics capabilities, building data-driven operating models, and improving outcomes through innovative analytics and data science.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/new-approach